Clinical Trial

Enarodustat Tablets at Different Initial Doses for Anemia in Non-dialysis CKD Patients

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
To evaluate the rationality of different initial doses of enarodustat for the treatment of anemia in ND-CKD patients
Trial Details
NCT Number NCT07079579
Lead Sponsor Shenzhen Salubris Pharmaceuticals Co., Ltd.
Conditions Renal Anemia in Non-dialysis Chronic Kidney Disease
Enrollment 120 participants
Start Date 2025-08
Primary Completion 2027-06 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2025-07-23